• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Radboud University - Developmental Therapeutics Review - Q4 2010 Product Image

Radboud University - Developmental Therapeutics Review - Q4 2010

  • Published: December 2010
  • 81 pages
  • Global Markets Direct

Radboud University – Developmental Therapeutics Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Radboud University – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.

Scope

- Review of therapeutics under development by Radboud University.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Radboud University with complete description of the READ MORE >



List of Tables
List of Figures
Radboud University Snapshot
Radboud University Overview
Key Information
Key Facts
Radboud University – Research and Development Overview
Key Therapeutic Areas
Radboud University – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Radboud University – Pipeline Products Glance
Radboud University – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Radboud University Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Radboud University – Drug Profiles
Accelerated radiotherapy
Product Description
Mechanism of Action
R&D Progress
Amitriptyline
Product Description
Mechanism of Action
R&D Progress
Amitriptyline + Pregabalin
Product Description
Mechanism of Action
R&D Progress
ATG Fresenius
Product Description
Mechanism of Action
R&D Progress
Celecoxib + Ursodeoxycholic Acid
Product Description
Mechanism of Action
R&D Progress
Cyclophosphamide + steroids
Product Description
Mechanism of Action
R&D Progress
Pregabalin
Product Description
Mechanism of Action
R&D Progress
Rituximab
Product Description
Mechanism of Action
R&D Progress
Vildagliptin + Acarbose
Product Description
Mechanism of Action
R&D Progress
Amitriptyline + Pregabalin
Product Description
Mechanism of Action
R&D Progress
Atazanavir
Product Description
Mechanism of Action
R&D Progress
Atazanavir + Raltegravir + Emtricitabine
Product Description
Mechanism of Action
R&D Progress
Atazanavir + Raltegravir + Lamivudine
Product Description
Mechanism of Action
R&D Progress
Autologous Dendritic Cell Vaccination
Product Description
Mechanism of Action
R&D Progress
Autologous dendritic cell vaccine
Product Description
Mechanism of Action
R&D Progress
autologous dendritic cells electroporated with mRNA
Product Description
Mechanism of Action
R&D Progress
Bevacizumab + Capecitabine + Oxaliplatin
Product Description
Mechanism of Action
R&D Progress
Capecitabine + Oxaliplatin
Product Description
Mechanism of Action
R&D Progress
Carbamazepine + Nevirapine
Product Description
Mechanism of Action
R&D Progress
carboplatin -gemcitabine + bevacizumab
Product Description
Mechanism of Action
R&D Progress
CEA-loaded dendritic cell vaccine
Product Description
Mechanism of Action
R&D Progress
Daclizumab + Dendritic Cell Based Vaccine
Product Description
Mechanism of Action
R&D Progress
Daclizumab + Dendritic cells vaccine
Product Description
Mechanism of Action
R&D Progress
Invirase + Norvir
Product Description
Mechanism of Action
R&D Progress
Kineret
Product Description
Mechanism of Action
R&D Progress
Liposomal Prednisolone
Product Description
Mechanism of Action
R&D Progress
long-circulating liposomal prednisolone
Product Description
Mechanism of Action
R&D Progress
Moxifloxacin
Product Description
Mechanism of Action
R&D Progress
Peptide-Pulsed Dendritic Cells
Product Description
Mechanism of Action
R&D Progress
PfLSA-3-rec Vaccine + Aluminum Hydroxide
Product Description
Mechanism of Action
R&D Progress
PfLSA-3-rec Vaccine + Montanide Isa 720
Product Description
Mechanism of Action
R&D Progress
Posaconazole
Product Description
Mechanism of Action
R&D Progress
posaconazole (PSZ)
Product Description
Mechanism of Action
R&D Progress
Rosiglitazone
Product Description
Mechanism of Action
R&D Progress
Tetracosactide Hexacetaat for Idiopathic Membranous Nephropathy
Product Description
Mechanism of Action
R&D Progress
Aminoguanidine
Product Description
Mechanism of Action
R&D Progress
capecitabine + irinotecan + sunitinib
Product Description
Mechanism of Action
R&D Progress
Capiri-sutent
Product Description
Mechanism of Action
R&D Progress
Fosamprenavir + Ritonavir + Olanzapine
Product Description
Mechanism of Action
R&D Progress
Isentress
Product Description
Mechanism of Action
R&D Progress
Lopinavir + Ritonavir
Product Description
Mechanism of Action
R&D Progress
MK-0518 + Lamotrigine
Product Description
Mechanism of Action
R&D Progress
Sorafenib + Sirolimus
Product Description
Mechanism of Action
R&D Progress
Temsirolimus + Caelyx
Product Description
Mechanism of Action
R&D Progress
Temsirolimus + Pegylated Liposomal Doxorubicin
Product Description
Mechanism of Action
R&D Progress
Radboud University – Pipeline Analysis
Radboud University – Pipeline Products by Therapeutic Class
Radboud University Pipeline Products By Target
Radboud University – Pipeline Products by Route of Administration
Radboud University – Pipeline Products by Molecule Type
Radboud University - Dormant Projects
Radboud University – Locations And Subsidiaries
Head Office
Recent Developments
Dec 17, 2007: Radboud University Publishes Research In Tuberculosis
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown

RELATED PRODUCTS